Bottleneck Solvers

BN · rank #11 · 2026-09-07

RMBS

NASDAQ · $9.24B (USD)

SignalBuy3.7strength 3.7 / 10
verdict · PROCEED

The exact numbers the algorithm saw.

Bottleneck themes
The structural shortage this name supplies into.
Advanced AI chip packaging and memory
Factor scores and the inputs behind this pick.
Composite score
Z-score blend of the factors below; drives the rank.
0.55
Forward revenue growth
Consensus forward revenue growth.
+20.0%
Forward net margin
Consensus forward net margin.
+32.4%
Net margin TTM
Trailing twelve month net margin.
+31.7%
Margin expansion
Forward minus trailing net margin (percentage points).
+0.7%
Forward PEG
Forward P/E to growth. Below 1 is cheap for the growth.
3.80
Debt / FCF
Net debt relative to free cash flow. Lower is safer.
0.07×
Analyst upside
Spread between the consensus 12m target and the current price.
+73.0%
Last EPS surprise
Most recent reported EPS versus consensus.
+10%
Market cap (USD)$9.24B

The AI research card

Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.

Summary

Rambus is a fabless semiconductor and IP licensing company supplying DDR5 memory interface chips, HBM/GDDR/PCIe/CXL controller IP, and security IP to data center, AI, and government customers.

Rationale

Record Q2 2026 revenue (+20% YoY), ~45% non-GAAP operating margins, a 10.3% EPS beat, and an expanding PCIe 7.0/CXL 3.1 portfolio directly confirm the bottleneck-solver thesis—Rambus sits at the memory and interconnect chokepoints that AI infrastructure scaling cannot bypass.

Material risks

  • 1Royalty revenue concentration risk—if hyperscaler customers (e.g., Samsung, SK Hynix, Micron) internalize memory interface IP or negotiate materially lower licensing rates, the $84M royalty stream that underpins margin quality could compress without warning.
  • 2Valuation is genuinely stretched at fwd PEG 3.8x; the 73% analyst upside implies consensus is pricing in flawless execution, leaving the stock vulnerable to any product revenue deceleration or CXL adoption timeline slip.

AI verdict council

Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.

OpenAI
Caution
Claude
Proceed
Gemini
Proceed